29 May 2024
Asahi Kasei to Acquire Calliditas Therapeutics for SEK 11.8 Billion
The acquisition will be executed through a voluntary tender offer, with major shareholders committed. It aligns with Asahi Kasei’s strategy to expand in healthcare, focusing on R&D and unmet medical needs.
